Adipocytokines and achievement of low disease activity in rheumatoid arthritis.
Sign Up to like & getrecommendations! Published in 2022 at "Seminars in arthritis and rheumatism"
DOI: 10.1016/j.semarthrit.2022.152003
Abstract: PURPOSE To determine if adipocytokines are independently associated with the achievement of low disease activity (LDA) over long-term follow-up in a large rheumatoid arthritis (RA) registry. METHODS This cohort study evaluated adults with RA from… read more here.
Keywords: disease activity; achievement low; low disease; disease ... See more keywords
Maintenance treatment using abatacept with dose reduction after achievement of low disease activity in patients with rheumatoid arthritis (MATADOR) – A prospective, multicenter, single arm pilot clinical trial
Sign Up to like & getrecommendations! Published in 2017 at "Modern Rheumatology"
DOI: 10.1080/14397595.2017.1286714
Abstract: Abstract Objectives: To preliminarily evaluate the feasibility of maintenance therapy with reduced dose of intravenous abatacept (ABT) to 250 mg/body/month after achieving remission or low disease activity (LDA). Patients and methods: RA patients treated with ABT… read more here.
Keywords: matador protocol; maintenance; disease; disease activity ... See more keywords
Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity
Sign Up to like & getrecommendations! Published in 2018 at "Rheumatology"
DOI: 10.1093/rheumatology/key233
Abstract: Objectives The progression of subclinical atherosclerosis in SLE and RA has not been comparatively assessed. We sought to investigate the impact of low disease activity and other disease-related factors on atherosclerosis progression in SLE vs… read more here.
Keywords: sle; disease; disease activity; low disease ... See more keywords
Tapering and discontinuation of systemic medications in psoriasis patients with low disease activity
Sign Up to like & getrecommendations! Published in 2020 at "Dermatologic Therapy"
DOI: 10.1111/dth.13599
Abstract: Psoriasis is a chronic disease and often requires long‐term treatment, especially in patients with moderate‐to‐severe psoriasis. It remains controversial whether the doses of systemic medications could be tapered or if these medications could be discontinued… read more here.
Keywords: patients low; disease; systemic medications; psoriasis patients ... See more keywords
Response to: ‘Remission or low disease activity as a target in systemic lupus erythematosus’ by Ugarte-Gil et al
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2017-212911
Abstract: We appreciated the comments by Ugarte-Gil and co-authors1 on our report dealing with lupus low disease activity state (LLDAS) in Caucasian patients.2 We agree that Caucasian patients with systemic lupus erythematosus (SLE) have a better… read more here.
Keywords: ugarte gil; remission; disease; disease activity ... See more keywords
OP0124 In sle patients in sustained low disease activity, novel interferon assays predict flares and glucocorticoid requirements
Sign Up to like & getrecommendations! Published in 2018 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2018-eular.3107
Abstract: Background Objectives of therapy in SLE are to maintain low disease activity and minimise glucocorticoid exposure. Disease activity is unpredictable with periods of low disease activity followed by flares. Once disease is controlled, there is… read more here.
Keywords: disease activity; low disease; activity; ifn score ... See more keywords
How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-215650
Abstract: Recently, two different studies1 2 applied the criteria of the Lupus Low Disease Activity State (LLDAS)3 to the data sets of the BLISS-524 and BLISS-765 phase III trials of belimumab. The studies reported similar LLDAS… read more here.
Keywords: state lldas; activity state; disease activity; low disease ... See more keywords
AB0364 DISCONTINUATION OF CONCOMITANT METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOCILIZUMAB: AN INTERVENTIONAL STUDY
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.221
Abstract: Background Methotrexate (MTX) is an important anchor drug for rheumatoid arthritis (RA) patients and is used alone or in combination with biologics. However, some patients discontinue MTX due to toxicity including gastrointestinal (GI) disorders [1].… read more here.
Keywords: disease activity; discontinuation; low disease; week ... See more keywords
THU0120 RHEUMATIC DISEASE COMORBIDITY INDEX IMPACT ON DISEASE ACTIVITY IN PATIENTS ENROLLED IN KUWAIT REGISTRY OF RHEUMATIC DISEASES (KRRD)
Sign Up to like & getrecommendations! Published in 2019 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2019-eular.445
Abstract: Background: Its known that the presence of certain comorbidities in patients with Rheumatoid arthritis (RA) can have an impact on the chance of achieving low disease activity (LDA). Objectives: The purpose of this study was… read more here.
Keywords: disease activity; comorbidity; patients enrolled; low disease ... See more keywords
AB0213 THE USE OF MUSCULOSKELETAL ULTRASOUND AND PATIENT REPORTED OUTCOMES TO IDENTIFY THE FACTOR TO GIVE RESIDUAL SYMPTOMS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS IN SDAI-REMISSION OR LOW DISEASE ACTIVITY.
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.2104
Abstract: The goal of treatment in rheumatoid arthritis (RA) is to achieve remission. There is the patient with residual symptoms in the Japanese RA patient who achieved clinical remission. There are not many studies to examine… read more here.
Keywords: patient; residual symptoms; low disease; disease ... See more keywords
THU0106 PREDICTORS OF FLARE IN RHEUMATOID ARTHRITIS PATIENTS WITH LOW DISEASE ACTIVITY
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.5202
Abstract: Low disease activity (LDA) in patients with rheumatoid arthritis (RA) are usually recognized as stable state. In according to most guidelines for RA, monotherapy of disease modifying anti-rheumatic drug (DAMRD) was recommended for RA patents… read more here.
Keywords: disease activity; arthritis; low disease; disease ... See more keywords